Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Aaron Gal's Stock Ratings
Bernstein Analyst
Aaron Gal is an analyst at Bernstein. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/25/2025
Overall Average Return
9.56%
Smart Score
Overall Average Return Percentile
59th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/17/2024 | GILD | Buy Now | Gilead Sciences | $107.24 | -2.09% | Aaron Gal55% | → $105 | Initiates | → Outperform | Get Alert |
| 10/17/2024 | ABBV | Buy Now | AbbVie | $185.70 | 9.32% | Aaron Gal55% | → $203 | Initiates | → Market Perform | Get Alert |
| 10/17/2024 | AMGN | Buy Now | Amgen | $277.01 | 37.18% | Aaron Gal55% | → $380 | Initiates | → Outperform | Get Alert |
| 03/11/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $523.00 | 115.11% | Aaron Gal55% | → $1125 | Initiates | → Outperform | Get Alert |
| 01/03/2022 | ABBV | Buy Now | AbbVie | $185.70 | -16.53% | Aaron Gal55% | $130 → $155 | Maintains | Outperform | Get Alert |
| 01/03/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $523.00 | 26.2% | Aaron Gal55% | → $660 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/15/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $523.00 | 26.2% | Aaron Gal55% | → $660 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/11/2021 | BIIB | Buy Now | Biogen | $126.70 | 294.63% | Aaron Gal55% | → $500 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/01/2021 | GILD | Buy Now | Gilead Sciences | $107.24 | -25.4% | Aaron Gal55% | → $80 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/14/2020 | VTRS | Buy Now | Viatris | $8.95 | 134.64% | Aaron Gal55% | → $21 | Initiates | → Market Perform | Get Alert |
| 10/09/2020 | AMGN | Buy Now | Amgen | $277.01 | — | Aaron Gal55% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/09/2020 | BIIB | Buy Now | Biogen | $126.70 | 134.41% | Aaron Gal55% | $360 → $297 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/06/2020 | GILD | Buy Now | Gilead Sciences | $107.24 | -34.73% | Aaron Gal55% | $78 → $70 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/30/2019 | BIIB | Buy Now | Biogen | $126.70 | — | Aaron Gal55% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 04/26/2019 | GILD | Buy Now | Gilead Sciences | $107.24 | — | Aaron Gal55% | — | Initiates | → Outperform | Get Alert |
| 04/26/2019 | GILD | Buy Now | Gilead Sciences | $107.24 | -23.54% | Aaron Gal55% | → $82 | Initiates | → Outperform | Get Alert |
| 04/01/2019 | CELG | Buy Now | Celgene | — | — | Aaron Gal55% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/19/2018 | BIIB | Buy Now | Biogen | $126.70 | — | Aaron Gal55% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/23/2018 | CELG | Buy Now | Celgene | — | — | Aaron Gal55% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/27/2017 | CELG | Buy Now | Celgene | — | — | Aaron Gal55% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/17/2017 | CELG | Buy Now | Celgene | — | — | Aaron Gal55% | → $162 | Initiates | → Outperform | Get Alert |
| 08/04/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.09 | — | Aaron Gal55% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/29/2016 | AMGN | Buy Now | Amgen | $277.01 | — | Aaron Gal55% | — | Initiates | → Market Perform | Get Alert |
| 06/29/2016 | BIIB | Buy Now | Biogen | $126.70 | — | Aaron Gal55% | — | Initiates | → Outperform | Get Alert |
| 07/27/2015 | BIIB | Buy Now | Biogen | $126.70 | 203.87% | Aaron Gal55% | $436 → $385 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/01/2012 | GILD | Buy Now | Gilead Sciences | $107.24 | — | Aaron Gal55% | — | Upgrade | Market Perform → Outperform | Get Alert |
